Panacos Pharmaceuticals, Inc.
PANC
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Revenue | -45.90% | -43.55% | 67.83% | -36.62% | -57.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -45.90% | -43.55% | 67.83% | -36.62% | -57.04% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -45.90% | -43.55% | 67.83% | -36.62% | -57.04% |
| SG&A Expenses | -13.57% | -5.34% | 2.80% | 6.72% | 13.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.13% | -10.04% | -11.20% | 3.69% | 5.36% |
| Operating Income | 9.95% | 9.88% | 11.43% | -4.01% | -6.10% |
| Income Before Tax | 2.88% | 3.53% | 13.90% | 1.71% | 2.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.88% | 3.53% | 13.90% | 1.71% | 2.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.88% | 3.53% | 13.90% | 1.71% | 2.45% |
| EBIT | 9.95% | 9.88% | 11.43% | -4.01% | -6.10% |
| EBITDA | 9.52% | 9.28% | 11.05% | -4.69% | -6.62% |
| EPS Basic | 4.44% | 6.25% | 17.62% | 6.81% | 7.70% |
| Normalized Basic EPS | 1.04% | 3.25% | 8.54% | -4.89% | -3.66% |
| EPS Diluted | 4.44% | 6.25% | 17.62% | 6.81% | 7.70% |
| Normalized Diluted EPS | 1.04% | 3.25% | 8.54% | -4.89% | -3.66% |
| Average Basic Shares Outstanding | 1.62% | 3.06% | 4.36% | 5.49% | 5.83% |
| Average Diluted Shares Outstanding | 1.62% | 3.06% | 4.36% | 5.49% | 5.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |